Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v10-FR
Language English French
Date Updated 2021-02-10 2020-10-20
Drug Identification Number 02443015 02443015
Brand name GALANTAMINE ER GALANTAMINE ER
Common or Proper name GALANTAMINE GALANTAMINE
Company Name SANIS HEALTH INC SANIS HEALTH INC
Ingredients GALANTAMINE GALANTAMINE
Strength(s) 8MG 8MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-06-01 2020-06-01
Actual start date 2020-06-03 2020-06-03
Estimated end date 2020-12-30 2020-11-30
Actual end date 2021-02-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments